| scholarly article | Q13442814 |
| P2093 | author name string | Jason S Knight | |
| Geoffrey D Barnes | |||
| Nayef M Kazzaz | |||
| Ruba Kado | |||
| Allecia M Wilson | |||
| P2860 | cites work | Cardiac manifestations in antiphospholipid syndrome | Q28211851 |
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival | Q28607141 | ||
| Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography | Q33334045 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome. | Q33372976 | ||
| Catastrophic APS in the context of other thrombotic microangiopathies | Q33419886 | ||
| The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features | Q33420116 | ||
| Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura | Q33451867 | ||
| Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability | Q33643432 | ||
| Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. | Q33956621 | ||
| The pathogenesis of the antiphospholipid syndrome | Q34332601 | ||
| Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome | Q35555909 | ||
| Coronary and valvular syndromes and antiphospholipid antibodies | Q35928744 | ||
| Coronary artery pathology | Q36057177 | ||
| Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review | Q36330065 | ||
| Non-bacterial thrombotic endocarditis | Q36946266 | ||
| Revisiting Libman-Sacks endocarditis: a historical review and update | Q37352871 | ||
| Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage | Q38132095 | ||
| Vasculitis in antiphospholipid syndrome | Q38268555 | ||
| Treatment of catastrophic antiphospholipid syndrome | Q38755260 | ||
| In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis | Q39328138 | ||
| Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome | Q39586997 | ||
| Vasculitis associated with antiphospholipid syndrome | Q40519209 | ||
| Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. | Q41818166 | ||
| Distinct renal injury in early atherosclerosis and renovascular disease | Q44114735 | ||
| The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients | Q44593960 | ||
| Polyarteritis nodosa and the antiphospholipid syndrome | Q49099812 | ||
| A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. | Q51059360 | ||
| 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. | Q51289629 | ||
| Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise. | Q53241480 | ||
| A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association | Q57222067 | ||
| Rapid change in pulmonary vascular hemodynamics with pulmonary edema during cardiopulmonary resuscitation | Q70057110 | ||
| Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases | Q71097704 | ||
| Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings | Q71115742 | ||
| Angiographic features associated with antiphospholipid syndrome | Q73363321 | ||
| Polyarteritis nodosa complicated by catastrophic antiphospholipid syndrome | Q79250902 | ||
| Does the presence of secondary antiphospholipid syndrome in patients with systemic lupus erythematodes accelerate carotid arteries intima-media thickness changes? | Q86737884 | ||
| Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use | Q88458190 | ||
| P433 | issue | 8 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| primary antiphospholipid syndrome | Q63878006 | ||
| P304 | page(s) | 1253-1259 | |
| P577 | publication date | 2016-12-19 | |
| P1433 | published in | Arthritis Care and Research | Q15754720 |
| P1476 | title | A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia | |
| P478 | volume | 69 |
Search more.